Editor’s Commentary: Regulatory Science and the Science of Safety

Author:

Turner J. Rick

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug guides,Pharmacology (nursing)

Reference26 articles.

1. Hamburg MA. Remarks at the National Press Club Speaker Luncheon. October 6, 2010. http://www.fda.gov/NewsEvents/Speeches/ucm229195.htm (accessed January 5, 2011).

2. Food and Drug Administration. Strategic priorities 2011–2015: responding to the public health challenges of the 21st century (draft). http://www.fda.gov/downloads/AboutFDA/ReportManualsForms/Reports/StrategicActionPlan/UCM226907.pdf (accessed January 5, 2011).

3. Food and Drug Administration. The Sentinel Initiative: national strategy for monitoring medical product safety. 2008. http://www.fda.gov/downloads/Safety/FDAsSentinellnitiative/UCM124701.pdf (accessed February 12. 2011).

4. Food and Drug Administration. The Sentinel Initiative: access to electronic healthcare data for more than 25 million lives: achieving FDAAA Section 905 goal one. http://www.fda.gov/downloads/Safety/FDAsSentinellnitiative/UCM233360.pdf (accessed February 12, 2011).

5. Institute of Medicine of the National Academies. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington. DC: National Academies Press; 2007. (Report released September 2006, published in book form in 2007: see also http://iom.edu/Reports/2006/The-Future-of-Drug-Safety-Promoting-and-Protecting-the-Health-of-the-Public.aspx. accessed February 12, 2011.)

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Meta-Methodology: Conducting and Reporting Meta-Analyses;The Journal of Clinical Hypertension;2013-11-04

2. Editor’s Commentary: Celebrating the Journal’s New Name— Therapeutic Innovation & Regulatory Science;Drug Information Journal;2012-07

3. Editor’s Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-Risk Estimation;Drug Information Journal;2011-09

4. Meta-Methodology;SpringerBriefs in Pharmaceutical Science & Drug Development;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3